Basecamp Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7K Buy
308
+37
+14% +$2.46K ﹤0.01% 801
2026
Q1
$17K Sell
271
-37
-12% -$2.58K ﹤0.01% 875
2025
Q4
$20.4K Buy
+308
New +$19.9K ﹤0.01% 785

Other funds holding DXCM

Basecamp Wealth Advisors's DXCM Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its DexCom (DXCM) stake by 14% in Q2 2026, buying an estimated $2.46K and bringing the position to 308 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Basecamp Wealth Advisors first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Basecamp Wealth Advisors held 308 shares of DexCom worth $20.7K as of Q2 2026.
  • Basecamp Wealth Advisors bought 37 DexCom shares in Q2 2026, an estimated $2.46K.
  • DexCom made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #801 holding.
  • Basecamp Wealth Advisors first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.